Stay updated with breaking news from Advaxis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Get Rating) in a research report sent to investors on Wednesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Ayala Pharmaceuticals Price Performance ADXS opened at $1.35 on Wednesday. The company has a market cap of $2.45 million, a price-to-earnings ratio […]
Should You Buy or Sell Ayala Pharmaceuticals Stock? Get The Latest ADXS Stock Forecast, Price Target, Headlines, Short Interest at MarketBeat.
Analysts at StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a note issued to investors on Sunday. The firm set a “sell” rating on the stock. Ayala Pharmaceuticals Price Performance About Ayala Pharmaceuticals (Get Rating) Advaxis, Inc is a biotechnology company, which engages in the discovery, development and commercialization of […]
Investment analysts at StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a research note issued on Saturday. The firm set a “sell” rating on the stock. Ayala Pharmaceuticals Price Performance About Ayala Pharmaceuticals (Get Rating) Advaxis, Inc is a biotechnology company, which engages in the discovery, development and commercialization of […]
StockNews.com started coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Get Rating) in a research report released on Monday. The firm issued a sell rating on the biotechnology company’s stock. Ayala Pharmaceuticals Price Performance Shares of OTCMKTS:ADXS opened at $1.50 on Monday. The firm has a market capitalization of $2.72 million, a PE ratio of […]